251
Participants
Start Date
September 14, 2020
Primary Completion Date
September 30, 2025
Study Completion Date
October 15, 2025
Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer PFO Occluder, ASO or Amplatzer Cribriform Occluder
Amplatzer Trevisio Delivery System is used for facilitating percutaneous, transcatheter implantation of the Amplatzer PFO Occluder, ASO or Amplatzer Cribriform Occluder.
Amplatzer™ Trevisio™ Intravascular Delivery System using Amplatzer Muscular VSD Occluder or Amplatzer Post-Infarct Muscular VSD Occluder
Amplatzer Trevisio Delivery System is used for facilitating percutaneous, transcatheter implantation of the Amplatzer Muscular VSD Occluder or Amplatzer Post-Infarct Muscular VSD Occluder.
Stadtspital Triemli, Zurich
Hopital d'adulte de la Timone, Marseille
Deutsches Herzzentrum Berlin, Berlin
Hospital Universitario Reina Sofia, Córdoba
Policlinico San Donato, San Donato Milanese
Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
Hospital Universitario de la Paz - Pediatrico, Madrid
Hospital Universitario de la Paz, Madrid
Herz- und Diabeteszentrum NRW, Bad Oeynhausen
Hopital Haut Leveque, Pessac
CHU Trousseau, Chambray-lès-Tours
CHU Hopital G. & R. Laënnec, Nantes
Fondazione Toscana Gabriele Monasterio Via Aurelia Sud, Massa
CHRU Lille, Lille
CHU Gabriel Montpied, Clermont-Ferrand
Azienda Ospedaliera Monaldi, Napoli
Deutsches Herzzentrum München des Freistaates Bayern, München
Centre Médico Chirurgical Marie Lannelongue, Le Plessis-Robinson
Amsterdam Academic Medical Centre (AMC), Amsterdam
Gornoslaskie Centrum Medyczne im.prof. Leszka Gieca ul., Katowice
Uniwersytekie Centrum Kliniczne, Gdansk
The Cardinal Stefan Wyszynski Institute of Cardiology, Warsaw
Lead Sponsor
Abbott Medical Devices
INDUSTRY